As of 10:30 AM on the 19th, Komipharm is trading at 13,100 KRW, the same price as the previous day. This represents a 16.56% decline compared to October 6. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.
Today, foreigners are tentatively recorded as net sellers of 1,962 shares. Over the past five days, individual investors have been net buyers of 47,729 shares, while foreigners and institutions have been net sellers of 25,930 shares and 18,325 shares, respectively.
On October 14, Komipharm became a market issue with a sharp drop following the news of the rejection of its clinical trial application for a COVID-19 treatment in Spain.
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
